ResMed Inc.
RMD
$219.72
-$0.50-0.23%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 10.68% | 6.54% | -2.75% | 43.91% | -4.84% |
Total Depreciation and Amortization | 4.76% | -1.54% | 0.22% | 3.11% | -0.03% |
Total Amortization of Deferred Charges | -0.87% | -4.52% | 0.12% | -2.51% | -0.86% |
Total Other Non-Cash Items | 15.71% | -44.79% | 491.88% | -88.78% | 135.71% |
Change in Net Operating Assets | -93.43% | -203.98% | 39.96% | 193.68% | -354.39% |
Cash from Operations | -5.20% | -26.03% | 9.47% | 47.35% | -4.70% |
Capital Expenditure | -15.72% | 28.30% | -17.41% | 9.26% | 22.25% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -539.72% | 58.97% | 92.73% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -176.94% | 1,135.01% | 78.26% | 13.64% | 34.75% |
Cash from Investing | -1,809.79% | 104.61% | -40.29% | 19.42% | 72.38% |
Total Debt Issued | -- | -- | -- | -- | -100.00% |
Total Debt Repaid | 83.33% | 90.00% | -36.36% | -69.23% | 29.73% |
Issuance of Common Stock | 220.61% | -69.73% | 466.13% | -74.94% | 1,886.16% |
Repurchase of Common Stock | -82.01% | 0.06% | -0.22% | 12.96% | -25,590.67% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | 0.25% | -10.40% | -0.09% | 0.26% | -0.11% |
Other Financing Activities | 100.00% | -- | -- | -- | 100.00% |
Cash from Financing | 2.14% | 61.67% | -17.08% | -40.57% | -58.11% |
Foreign Exchange rate Adjustments | -360.18% | 8,483.72% | 102.43% | -163.00% | 269.61% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -49.16% | 41,585.14% | -98.37% | 2,311.77% | 106.10% |